Skip to content

Biohaven

US · BHVN #2805 by market cap Listed 2017
12.39 -1.26 -9.23%
Periodic snapshot; not a real-time feed. · 2026-11-20 20:01

Recent news

  • CCORF Maintains Biohaven(BHVN.US) With Buy Rating, Raises Target Price to $32
    Market Newswire · 2026/10/30
  • Rating change
    RBC Capital Maintains Biohaven(BHVN.US) With Hold Rating, Maintains Target Price $19
    Market Newswire · 2026/10/17
  • Earnings Flash (BHVN) Biohaven Ltd. Posts Q3 Adjusted Loss $0.73 per Share, Vs. FactSet Est of $-0.78
    MT Newswires · 2026/10/30
  • Rating change
    Citi Maintains Biohaven(BHVN.US) With Buy Rating, Maintains Target Price $17
    Market Newswire · 2026/9/18
  • Rating change
    RBC Capital Maintains Biohaven(BHVN.US) With Hold Rating, Maintains Target Price $22
    Market Newswire · 2026/10/28
  • Company notice
    Biohaven: Biohaven Pharmaceutical Holding Company Ltd. - Anticipated Adjustment Option Symbol: BHVN New Symbol: To be determined
    OCC · 2022/9/13
  • Rating change
    Analysts Offer Insights on Healthcare Companies: Surrozen (SRZN), Gilead Sciences (GILD) and Biohaven Ltd. (BHVN)
    TipRanks · 2026/10/13
  • BofA Securities Maintains Biohaven(BHVN.US) With Sell Rating
    Market Newswire · 2026/10/31
  • Company notice
    Biohaven: Biohaven Pharmaceutical Holding Company Ltd. - Contract Adjustment Option Symbol: BHVN New Symbol: BHVN1
    OCC · 2022/10/3
  • Rating change
    RBC Capital Sticks to Its Hold Rating for Biohaven Ltd. (BHVN)
    TipRanks · 2026/10/23
  • Rating change
    J.P. Morgan Maintains Biohaven(BHVN.US) With Buy Rating
    Market Newswire · 2026/9/14
  • Rating change
    BofA Securities Maintains Biohaven(BHVN.US) With Sell Rating, Maintains Target Price $11
    Market Newswire · 2026/10/13
  • Rating change
    Baird Maintains Biohaven(BHVN.US) With Buy Rating, Cuts Target Price to $48
    Market Newswire · 2026/10/23
  • Rating change
    CCORF Maintains Biohaven(BHVN.US) With Buy Rating, Maintains Target Price $21
    Market Newswire · 2026/10/23
  • Rating change
    Biohaven Ltd. (BHVN) Receives a Buy From Canaccord Genuity
    TipRanks · 2026/10/23
  • Morgan Stanley Maintains Biohaven(BHVN.US) With Buy Rating, Raises Target Price to $21
    Market Newswire · 2026/11/3
  • Rating change
    Analysts' Top Healthcare Picks: Biohaven Ltd. (BHVN), Clover Health Investments (CLOV)
    TipRanks · 2026/10/9
  • Rating change
    Analysts Offer Insights on Healthcare Companies: Alnylam Pharma (ALNY), AxoGen (AXGN) and Biohaven Ltd. (BHVN)
    TipRanks · 2026/9/30
  • Rating change
    RBC Capital Maintains Biohaven(BHVN.US) With Hold Rating, Raises Target Price to $22
    Market Newswire · 2026/10/23
  • TD Cowen Maintains Biohaven(BHVN.US) With Buy Rating, Maintains Target Price $30
    Market Newswire · 2026/10/30
  • Rating change
    Analysts Are Bullish on Top Healthcare Stocks: Biohaven Ltd. (BHVN), Boston Scientific (BSX)
    TipRanks · 2026/9/14
  • Rating change
    Raymond James Maintains Biohaven(BHVN.US) With Buy Rating
    Market Newswire · 2026/9/10
  • Rating change
    Analysts' Opinions Are Mixed on These Healthcare Stocks: Gossamer Bio (GOSS) and Biohaven Ltd. (BHVN)
    TipRanks · 2026/8/27
  • CCORF Maintains Biohaven(BHVN.US) With Buy Rating, Maintains Target Price $21
    Market Newswire · 2026/10/9
  • Rating change
    Analysts' Opinions Are Mixed on These Healthcare Stocks: Regeneron (REGN), Cytokinetics (CYTK) and Biohaven Ltd. (BHVN)
    TipRanks · 2026/9/10

Headlines are aggregated automatically and are not independently verified or edited by our team.

Quote time 2026-11-20 20:01:17 · For reference only, not investment advice and not tailored to your situation.

Biohaven discussion 0 comments

Add a comment